PIPELINE BIOTECH A/S: Financial statements 2013
CVR: 21672432
Source: annual report 2013, Danish Business Authority
01/05/2012 – 30/04/2013
PIPELINE BIOTECH A/S (CVR 21672432) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 9,623,036 and a net result of DKK 51,655. Equity in the 2013 report amounted to DKK 1,748,878. The solvency ratio was 13.4%.
- Gross Profit
- DKK 9,623,036
- Profit/Loss
- DKK 51,655
- Equity
- DKK 1,748,878
- Total Assets
- DKK 13,051,609
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of November 8, 2013, REVISIONSFIRMAET EDELBO STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PIPELINE BIOTECH A/S.
As of November 8, 2013, Revisions Firmaet Edelbo Statsautoriseret Revisionsvirksomhed I/S has stepped down as auditor of PIPELINE BIOTECH A/S.
About PIPELINE BIOTECH A/S
PIPELINE BIOTECH A/S was a Danish company of the type Aktieselskab based in Trige, founded in 1999. The company has been dissolved on 29 June 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 4 employees (2016). In 2015, the company reported a gross profit of DKK 4,402,408 and a net result of DKK -981,514 compared with DKK 113,245 the year before. Equity in the 2015 report amounted to DKK 880,607.